Market Currents
Shares of Jazz Pharmaceuticals' (JAZZ +15%) jump on a favorable Markman ruling defining the...
-
Monday, September 17, 2012, 3:58 PM ETShares of Jazz Pharmaceuticals' (JAZZ +15%) jump on a favorable Markman ruling defining the patent claim terms related to its narcolepsy medication Xyrem. Jefferies analyst Corey Davis says upon first read, the patent construction ruling "seems like a clear win for Jazz."
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
